On September 5, 2023, Bridge Biotherapeutics, Inc. closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
62,600 KRW | -1.26% |
|
-6.57% | -3.69% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-3.69% | 1.65B | |
+16.42% | 122B | |
+19.02% | 113B | |
+3.14% | 22.66B | |
-16.20% | 21.34B | |
-39.57% | 16.92B | |
-11.63% | 16.68B | |
-16.15% | 16.61B | |
+2.68% | 13.62B | |
+21.16% | 11.04B |
- Stock Market
- Equities
- A141080 Stock
- News LigaChem Biosciences Inc.
- Bridge Biotherapeutics, Inc. announced that it has received KRW 5.9999904 billion in funding from LegoChem Biosciences, Inc.